Profiles for companies starting with 'j'
✉ Email this page to a colleague
Drugs and US Patents for j
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Generics | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 205482-002 | Apr 24, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Janssen Biotech | BALVERSA | erdafitinib | TABLET;ORAL | 212018-001 | Apr 12, 2019 | RX | Yes | No | 11,684,620 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Janssen Pharms | ORTHO-CEPT | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 020301-002 | Dec 14, 1992 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Janssen Biotech | BALVERSA | erdafitinib | TABLET;ORAL | 212018-003 | Apr 12, 2019 | RX | Yes | Yes | 10,898,482 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
